Clinical Trial Update: Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands [Phase 4]

View source ↗

Summary

Phase 4 trial results evaluating the safety and efficacy of Imiquimod 5% Cream for actinic keratosis on the arms and hands have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Imiquimod 5% cream (Imiquimod)

Snippet

Sponsor: Graceway Pharmaceuticals, LLC | Conditions: Keratosis | Phase 4 | Status: COMPLETED